| Companies sponsors |
Biogen (natalizumab) |
| |
Sandoz (Tyruko (natalizumab biosimilar)) |
| Others |
Department of Health and Social Care |
| |
Health Technology Wales (HTW) |
| |
NHS England |
| |
Welsh Government |
| Patient carer groups |
Multiple Sclerosis Society |
| |
Multiple Sclerosis Trust |
| Professional groups |
Association of British Neurologists |
| |
Royal College of Physicians |
| Associated public health groups |
Public Health Wales |
| |
UK Health Security Agency |
| Comparator companies |
Janssen-Cilag (ponesimod) (confidentiality agreement signed, participating) |
| |
Merck Serono (cladribine, interferon beta-1a) (confidentiality agreement signed, participating) |
| |
Novartis Pharmaceuticals (fingolimod, interferon beta-1a, interferon beta-1b, ofatumumab) (confidentiality agreement signed, participating) |
| |
Amarox (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Bayer (interferon beta-1a, interferon beta-1b) (confidentiality agreement not signed, not participating) |
| |
Biocon Pharma (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Biogen Idec (interferon beta-1a) (confidentiality agreement not signed, not participating) |
| |
Dr. Reddy's Laboratories (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Glenmark Pharmaceuticals (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Mylan (fingolimod, glatiramer acetate, teriflunomide) (confidentiality agreement not signed, not participating) |
| |
Roche Products (ocrelizumab) (confidentiality agreement not signed, not participating) |
| |
Sandoz (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Sanofi Genzyme (alemtuzumab) (confidentiality agreement not signed, not participating) |
| |
Sun Pharma (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Teva (fingolimod, glatiramer acetate) (confidentiality agreement not signed, not participating) |
| |
Tillomed Laboratories (fingolimod) (confidentiality agreement not signed, not participating) |
| |
Zenvita (fingolimod) (confidentiality agreement not signed, not participating) |
| General commentators |
All Wales Therapeutics and Toxicology Centre |
| |
British National Formulary |
| |
Department of Health - Northern Ireland |
| |
Healthcare Improvement Scotland |
| |
Medicines and Healthcare products Regulatory Agency |
| |
Welsh Health Specialised Services Committee |
| Relevant research groups |
Brain Research UK |
| |
Cochrane Multiple Sclerosis and Rare Diseases of the Central Nervous System Group |
| |
Cochrane UK |
| |
Genomics England |
| |
MRC Clinical Trials Unit |